Tuesday, 02 January 2024 12:17 GMT

Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, And Revenue Forecasts


(MENAFN- GlobeNewsWire - Nasdaq) The Biopsy Devices market is projected to reach $4.02 billion by 2033, growing from $2.43 billion in 2024 at a CAGR of 5.75%. This growth is driven by personalized care demand, rising cancer cases, and minimally invasive treatments enhancing patient comfort. Key biopsy devices include needle, punch, and surgical tools for various medical needs. Advancements in biopsy technology ensure precise, early cancer detection and improved patient outcomes. Leading companies like Cardinal Health, Hologic, and Danaher are pivotal in this industry expansion. Investing in innovative solutions like AI-powered ColonPRO or SecureFlex devices underscores the market's commitment to evolving healthcare technologies.

Dublin, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The "Biopsy Devices Market: Key Players Analysis Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts" report has been added to ResearchAndMarkets's offering.
The Biopsy Devices market is anticipated to grow at US$ 4.02 billion by 2033 from US$ 2.43 billion in 2024 at a CAGR of 5.75% during the period of 2025 to 2033. A few of the primary drivers of the market include the increasing need for personalized care, the increasing prevalence of cancer, and the need for minimally invasive treatments to enhance patient comfort and reduce recovery times.

Biopsy equipment are medical devices used to remove tissue samples from the body for the purposes of diagnosis. Biopsy equipment is very important in disease identification, especially cancer, since it enables doctors to examine cells in a laboratory environment. There are different types of biopsy equipment such as needle biopsy equipment, punch biopsy equipment, and surgical biopsy tools, each specific to a different medical condition or body area.
Needle biopsy machines, including fine-needle aspirators and core needle biopsy systems, can be utilized for non-invasive sampling, enabling physicians to obtain tissue with minimal effect on healthy tissue in the area. Punch biopsy equipment is frequently used for skin sampling, whereas surgical biopsy equipment can be required for deeper or more extensive tissue sampling.
Use of biopsy devices makes early diagnosis and correct detection possible, allowing for timely and suitable treatment strategies. Biopsy devices are becoming more accurate and less invasive as technology evolves, making them more comfortable for patients and enhancing the quality of care. Their role in contemporary medicine cannot be overemphasized since they offer critical information for guiding treatment and improving patient care.

Key Attributes:

Report Attribute Details
No. of Pages 200
Forecast Period 2024 - 2033
Estimated Market Value (USD) in 2024 $2.43 Billion
Forecasted Market Value (USD) by 2033 $4.02 Billion
Compound Annual Growth Rate 5.7%
Regions Covered Global


Revenue Analysis

  • Cardinal Health, Inc
  • Hologic, Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Medtronic plc.
  • Olympus Corporation
  • CONMED Corporation
  • Argon Medical Devices, Inc.
  • Cook Medical (Cook Group)
  • INRAD, Inc.
  • FUJIFILM Holdings Corporation
  • Stryker Corporation
  • Merit Medical Systems, Inc.
  • B. Braun Melsungen AG

Global Biopsy Devices Market

  • Historical Trends
  • Forecast Analysis

Market Share Analysis - Global Biopsy Devices Industry

Company Analysis

Overview

  • Company History and Mission
  • Business Model and Operations
  • Workforce

Key Persons

  • Executive Leadership
  • Operational Management
  • Division Leaders
  • Board Composition

Recent Development & Strategies

  • Mergers & Acquisitions
  • Partnerships
  • Investments

Sustainability Analysis

  • Renewable Energy Adoption
  • Energy-Efficient Infrastructure
  • Use of Sustainable Packaging Materials
  • Water Usage and Conservation Strategies
  • Waste Management and Circular Economy Initiatives

Product Analysis

  • Product Profile
  • Quality Standards
  • Product Pipeline
  • Product Benchmarking

Strategic Assessment: SWOT Analysis

  • Strengths
  • Weaknesses
  • Opportunities
  • Threats

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Biopsy Devices Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN10112025004107003653ID1110321156



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search